HUP2200312A1 - Kariprazin tartalmú szájban diszpergálódó tabletta - Google Patents

Kariprazin tartalmú szájban diszpergálódó tabletta

Info

Publication number
HUP2200312A1
HUP2200312A1 HU2200312A HUP2200312A HUP2200312A1 HU P2200312 A1 HUP2200312 A1 HU P2200312A1 HU 2200312 A HU2200312 A HU 2200312A HU P2200312 A HUP2200312 A HU P2200312A HU P2200312 A1 HUP2200312 A1 HU P2200312A1
Authority
HU
Hungary
Prior art keywords
orally disintegrating
tablet containing
pharmaceutical tablet
disintegrating pharmaceutical
containing cariprazine
Prior art date
Application number
HU2200312A
Other languages
English (en)
Inventor
Melinda Dr Konta
Gergely Szakonyi
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to HU2200312A priority Critical patent/HUP2200312A1/hu
Priority to PCT/IB2023/057889 priority patent/WO2024028819A1/en
Publication of HUP2200312A1 publication Critical patent/HUP2200312A1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Addiction (AREA)
  • Medicinal Preparation (AREA)
HU2200312A 2022-08-05 2022-08-05 Kariprazin tartalmú szájban diszpergálódó tabletta HUP2200312A1 (hu)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU2200312A HUP2200312A1 (hu) 2022-08-05 2022-08-05 Kariprazin tartalmú szájban diszpergálódó tabletta
PCT/IB2023/057889 WO2024028819A1 (en) 2022-08-05 2023-08-04 Orally disintegrating pharmaceutical tablet containing cariprazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU2200312A HUP2200312A1 (hu) 2022-08-05 2022-08-05 Kariprazin tartalmú szájban diszpergálódó tabletta

Publications (1)

Publication Number Publication Date
HUP2200312A1 true HUP2200312A1 (hu) 2024-02-28

Family

ID=89662363

Family Applications (1)

Application Number Title Priority Date Filing Date
HU2200312A HUP2200312A1 (hu) 2022-08-05 2022-08-05 Kariprazin tartalmú szájban diszpergálódó tabletta

Country Status (2)

Country Link
HU (1) HUP2200312A1 (hu)
WO (1) WO2024028819A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118526462A (zh) * 2024-07-25 2024-08-23 山东则正医药技术有限公司 不同规格溶出行为相似的盐酸卡利拉嗪口崩片及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227534B1 (en) 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
SI2317852T1 (sl) * 2008-07-16 2015-04-30 Richter Gedeon Nyrt. Farmacevtske formulacije, ki vsebujejo ligande dopaminskega receptorja
CN107970217A (zh) 2016-10-25 2018-05-01 浙江京新药业股份有限公司 卡利拉嗪口腔崩解片及其制备方法
HUP1700253A1 (hu) * 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények

Also Published As

Publication number Publication date
WO2024028819A1 (en) 2024-02-08

Similar Documents

Publication Publication Date Title
EP3996695A4 (en) CANNABIDIOL TABLETS DISSOLVING IN THE MOUTH
HUP2200312A1 (hu) Kariprazin tartalmú szájban diszpergálódó tabletta
PL3597418T3 (pl) Zwrotnica wylotu tabletek tabletkarki
IL218643A0 (en) Orally disintegrating pharmaceutical dosage form containing aripiprazole
WO2010081722A3 (en) Orally disintegrating tablets for the treatment of pain
EP4238556A4 (en) GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM
IL304354A (en) Ridinilazole solid tablet dosage form
GB202200753D0 (en) Pharmaceutical compounds
CA200107S (en) Pharmaceutical tablet
CA199175S (en) Pharmaceutical tablet
CA199173S (en) Pharmaceutical tablet
CA199170S (en) Pharmaceutical tablet
EP4215174A4 (en) TABLET CASSETTE
EP4052699A4 (en) MEDICINE IN SOLID PHARMACEUTICAL FORM ADMINISTERED ORALLY
CA222831S (en) Tablet computer
CA215794S (en) Tablet computer
CA215795S (en) Tablet computer
EP3923931A4 (en) ORALLY DISINTEGRATING TABLETS COMPRISING GLYCOPYRROLATE AND METHODS FOR ENHANCING BIOAVAILABILITY
CA218485S (en) Tablet stand
EP4056638A4 (en) CELLULOSIC COMPOSITION, TABLET AND DISCOMPOSING TABLET IN THE MOUTH
EP4059502A4 (en) METAL TABLET
WO2012111961A3 (ko) 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
GB202319953D0 (en) Tablet formulations involving alvelestat
AU2020903726A0 (en) Freeze-dry orally disintegrating supplement tablet production processes
GB202304987D0 (en) Combination pharmaceutical